Latest New Zealand News

Page 20 of 237
Qube Holdings Limited will be removed from the S&P/ASX 200 Index before trading opens on July 9, 2026, following its pending acquisition by Rubik Australia, pending final court approval. Develop Global Limited will take its place in the index.
Claire Turing
Claire Turing
3 July 2026
Echelon Resources has finalised its exit from Cue Energy Resources following Horizon Oil's takeover, converting its Cue shares into cash and Horizon stock while cutting debt.
Maxwell Dee
Maxwell Dee
3 July 2026
Kingston Resources has launched a fully underwritten $8.47 million rights issue priced at 3.5 cents per share to support a major drilling campaign and plant expansion at its Mineral Hill project.
Maxwell Dee
Maxwell Dee
3 July 2026
Archer Materials has raised $7 million through a placement and launched a $3 million share purchase plan, backing its strategic partnership with IonQ to develop sovereign quantum computing in Australia.
Sophie Babbage
Sophie Babbage
3 July 2026
KGL Resources has launched a $120 million entitlement offer at $0.20 per share, part of a $300 million capital raise to fund the Jervois Copper Project. The offer is underwritten except for pre-commitments from major shareholders, with new shares expected to be issued late July.
Maxwell Dee
Maxwell Dee
3 July 2026
Orthocell has secured a strategic foothold in Thailand's $84 million nerve repair sector by appointing MediTime as exclusive Remplir distributor, leveraging established clinical networks to accelerate market penetration.
Ada Torres
Ada Torres
3 July 2026
Suncorp has secured a disciplined FY27 reinsurance program featuring a $800 million annual aggregate cover over five years, while signalling higher reinsurance costs and a $250 million natural hazard cost overrun in FY26.
Claire Turing
Claire Turing
3 July 2026
Meridian Energy has received final approval to ease access restrictions on Lake Pūkaki hydro storage for three years, reducing dry-year risk and enhancing supply security through to Winter 2028.
Maxwell Dee
Maxwell Dee
3 July 2026
Telix Pharmaceuticals has gained FDA alignment to advance Part 2 of its ProstACT Global Phase 3 trial for TLX591-Tx in metastatic castration-resistant prostate cancer, setting the stage for U.S. enrolment pending regulatory approval.
Ada Torres
Ada Torres
2 July 2026
Algorae Pharmaceuticals has been appointed as a supplier under a NSW Health public hospital supply contract, marking a strategic milestone despite uncertain immediate revenue impact.
Ada Torres
Ada Torres
2 July 2026
Intelligent Monitoring Group (ASX:IMB) has agreed to acquire ADT's UK residential security business for GBP 180 million, doubling its scale and entering a fast-growing market. The deal is expected to add 40% to EPS on a pro forma basis without requiring external equity.
Victor Sage
Victor Sage
2 July 2026
Constellation Resources has launched a one-for-three entitlement offer priced at $0.12 per share, inviting eligible shareholders across four countries to participate in a $3.22 million capital raise.
Maxwell Dee
Maxwell Dee
2 July 2026

Browse the archive

Full archive